What is Element Science?
Element Science is a pioneering med tech enterprise dedicated to revolutionizing cardiac health through the development of the Jewel Patch. This innovative wearable cardioverter defibrillator is engineered to provide continuous, non-invasive protection for patients at risk of sudden cardiac arrest. By integrating advanced sensor technology with sophisticated algorithms, the company aims to bridge the gap between clinical monitoring and patient safety. Element Science operates at the intersection of digital health and cardiology, focusing on FDA-approved solutions that empower patients while providing clinicians with actionable data. Their commitment to fostering a diverse and innovative workforce has been instrumental in maintaining their competitive edge within the rapidly evolving landscape of wearable medical devices.
How much funding has Element Science raised?
Element Science has raised a total of $263.4M across 4 funding rounds:
Series A
$12.5M
Private Equity
$25M
Series B
$80.3M
Series C
$145.6M
Series A (2014): $12.5M with participation from Third Rock Ventures, GV, and Prospect Venture Partners
Private Equity (2016): $25M, investors not publicly disclosed
Series B (2020): $80.3M supported by Fidelity Management & Research Company, JS Capital LLC, Venrock, and Foresite Capital
Series C (2020): $145.6M featuring Third Rock Ventures, Deerfield Healthcare, Qiming Venture Partners USA, Cormorant Asset Management, Google Ventures, and Invus Opportunities
Key Investors in Element Science
Third Rock Ventures
A healthcare venture firm focused on disruptive science and medicine, dedicated to launching companies that make a dramatic difference in patient lives.
Cormorant Asset Management
A prominent life sciences investment firm that provides financial resources to support innovative companies in the biotech and allied sectors.
Google Ventures
A global venture capital firm that invests across multiple stages and sectors, with a strong focus on life sciences and frontier technology innovations.
What's next for Element Science?
With the successful closure of its latest financing round, Element Science is poised to transition into a new phase of operational scaling and market expansion. The strategic capital will likely be deployed to support large-scale clinical trials, enhance manufacturing capabilities, and broaden the reach of the Jewel Patch platform. As the company moves toward wider adoption, the focus will remain on navigating regulatory pathways and strengthening its market presence in the cardiovascular space. Investors are closely watching how the firm leverages this backing to solidify its leadership in the wearable defibrillator market, potentially setting a new standard for patient-centric cardiac care.
See full Element Science company page
